Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load

B Li, Z Liu, X Liu, D Liu, M Duan, Y Gu, Q Liu… - Hepatology …, 2021 - Springer
Abstract Background Hepatitis B virus (HBV) infection is a significant global health problem
and> 42–52% of patients are infected during perinatal period. Tenofovir alafenamide …
被引用次数：38 相关文章

Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load

B Li, Z Liu, X Liu, D Liu, M Duan, Y Gu, Q Liu, Q Ma… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Hepatitis B virus (HBV) infection is a significant global health problem and> 42-
52% of patients are infected during perinatal period. Tenofovir alafenamide fumarate (TAF) …

Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load.

B Li, Z Liu, X Liu, D Liu, M Duan, Y Gu, Q Liu… - Hepatology …, 2021 - europepmc.org
Background Hepatitis B virus (HBV) infection is a significant global health problem and> 42-
52% of patients are infected during perinatal period. Tenofovir alafenamide fumarate (TAF) …